Ling Xue

2.1k total citations
81 papers, 1.5k citations indexed

About

Ling Xue is a scholar working on Computational Theory and Mathematics, Molecular Biology and Spectroscopy. According to data from OpenAlex, Ling Xue has authored 81 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Computational Theory and Mathematics, 22 papers in Molecular Biology and 14 papers in Spectroscopy. Recurrent topics in Ling Xue's work include Computational Drug Discovery Methods (25 papers), Analytical Chemistry and Chromatography (13 papers) and Pharmacogenetics and Drug Metabolism (10 papers). Ling Xue is often cited by papers focused on Computational Drug Discovery Methods (25 papers), Analytical Chemistry and Chromatography (13 papers) and Pharmacogenetics and Drug Metabolism (10 papers). Ling Xue collaborates with scholars based in China, United States and Spain. Ling Xue's co-authors include Jürgen Bajorath, Jeffrey W. Godden, Florence L. Stahura, Liyan Miao, Liyan Miao, Yan Zhang, Jin Wang, Limei Zhao, HE Xiao-jing and W. G. Rudd and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Frontiers in Immunology.

In The Last Decade

Ling Xue

77 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Xue China 21 597 590 295 159 129 81 1.5k
Heinz Schmidli Switzerland 31 274 0.5× 176 0.3× 155 0.5× 64 0.4× 112 0.9× 78 2.6k
Volker Fischer United States 29 694 1.2× 290 0.5× 274 0.9× 221 1.4× 1.4k 10.6× 88 3.5k
Cynthia Grondin United States 16 1.6k 2.7× 753 1.3× 155 0.5× 20 0.1× 229 1.8× 26 2.6k
Yin Huang China 20 1.2k 2.0× 646 1.1× 68 0.2× 159 1.0× 175 1.4× 65 2.3k
Philip T. Sager United States 40 1.8k 3.1× 384 0.7× 235 0.8× 13 0.1× 91 0.7× 142 7.7k
Maria Teresa Rocchetti Italy 29 1.1k 1.8× 53 0.1× 135 0.5× 125 0.8× 95 0.7× 96 2.5k
Stefan Krämer Germany 22 1.0k 1.7× 413 0.7× 39 0.1× 130 0.8× 12 0.1× 70 2.3k
Lars Kuepfer Germany 26 1.6k 2.6× 207 0.4× 146 0.5× 103 0.6× 396 3.1× 56 2.7k
Norman Stockbridge United States 35 2.0k 3.4× 298 0.5× 152 0.5× 16 0.1× 112 0.9× 143 4.9k
Daisuke Nakai Japan 25 756 1.3× 97 0.2× 143 0.5× 52 0.3× 496 3.8× 85 2.7k

Countries citing papers authored by Ling Xue

Since Specialization
Citations

This map shows the geographic impact of Ling Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Xue more than expected).

Fields of papers citing papers by Ling Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Xue. The network helps show where Ling Xue may publish in the future.

Co-authorship network of co-authors of Ling Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Xue. A scholar is included among the top collaborators of Ling Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Xue. Ling Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xue, Ling, et al.. (2024). Dynamics and implications of anti-drug antibodies against adalimumab using ultra-sensitive and highly drug-tolerant assays. Frontiers in Immunology. 15. 1429544–1429544. 1 indexed citations
2.
Xue, Ling, Linsheng Liu, Yun Li, et al.. (2024). Optimising infliximab induction dosing to achieve clinical remission in Chinese patients with Crohn’s disease. Frontiers in Pharmacology. 15. 1430120–1430120. 1 indexed citations
3.
4.
Huang, Chenrong, Ling Xue, Zheng Jiao, et al.. (2022). The Correlation Between Busulfan Exposure and Clinical Outcomes in Chinese Pediatric Patients: A Population Pharmacokinetic Study. Frontiers in Pharmacology. 13. 905879–905879. 3 indexed citations
5.
Qu, Hai, et al.. (2021). Experimental Investigation of Proppant Transport in Flexural Fracture Systems.
6.
Li, Ming, et al.. (2021). rno-miR-128-3p promotes apoptosis in rat granulosa cells (GCs) induced by norepinephrine through Wilms tumor 1 (WT1). In Vitro Cellular & Developmental Biology - Animal. 57(8). 775–785. 5 indexed citations
7.
8.
Xue, Ling, et al.. (2019). Multicenter-Based Population Pharmacokinetic Analysis of Ciclosporin in Hematopoietic Stem Cell Transplantation Patients. Pharmaceutical Research. 37(1). 15–15. 9 indexed citations
9.
Huang, Chenrong, Fan Xia, Ling Xue, et al.. (2019). Coadministration of vindesine with high-dose methotrexate therapy increases acute kidney injury via BCRP, MRP2, and OAT1/OAT3. Cancer Chemotherapy and Pharmacology. 85(2). 433–441. 12 indexed citations
10.
Wang, Taotao, Miao Yan, Dan Tang, et al.. (2018). Therapeutic drug monitoring and safety of voriconazole therapy in patients with Child–Pugh class B and C cirrhosis: A multicenter study. International Journal of Infectious Diseases. 72. 49–54. 39 indexed citations
11.
Chen, Yafang, Ling Xue, Shusen Sun, et al.. (2017). Evaluating biapenem dosage regimens in intensive care unit patients with Pseudomonas aeruginosa infections: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation. International Journal of Antimicrobial Agents. 51(3). 484–487. 11 indexed citations
12.
Xue, Ling, et al.. (2014). Population Pharmacokinetics and Individualized Dosage Prediction of Cyclosporine in Allogeneic Hematopoietic Stem Cell Transplant Patients. The American Journal of the Medical Sciences. 348(6). 448–454. 13 indexed citations
13.
Xue, Ling, et al.. (2011). Multimodel Bayesian Optimization of Data Collection Schemes. AGU Fall Meeting Abstracts. 2011.
14.
Yu, Danqing, Ji-yan Chen, Ling Xue, et al.. (2011). Effect of atorvastatin therapy on borderline vulnerable lesions in patients with acute coronary syndrome. Archives of Medical Science. 3(3). 433–439. 12 indexed citations
15.
Zhang, Yan, Jin Wang, Limei Zhao, et al.. (2011). Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients. European Journal of Clinical Pharmacology. 67(9). 885–887. 94 indexed citations
16.
Jiang, Xiaoman, et al.. (2010). Simultaneous Determination of 4-Methyl-Piperazine-1-Carbodithioc Acid 3-Cyano-3,3-Diphenylpropyl Ester Hydrochloride and its Major Metabolite in Rats by HPLC. Journal of Chromatographic Science. 48(2). 125–129. 5 indexed citations
17.
Lin, Jie, et al.. (2010). An Adaptive Heterogeneous Multiple Ant Colonies Algorithm. Journal of Intelligent Systems. 19(4). 301–314. 1 indexed citations
18.
Xue, Ling, Chao Li, & Xiong Zhang. (2006). Design of content-based video retrieval system using MPEG-7. Beijing Hangkong Hangtian Daxue xuebao. 32(7). 865. 1 indexed citations
19.
Xue, Ling, Florence L. Stahura, & Jürgen Bajorath. (2004). Cell-Based Partitioning. Methods in molecular biology. 275. 279–289. 14 indexed citations
20.
Liu, Hua, et al.. (2001). Calmodulin-Binding Protein BP-10, a Probable New Member of Plant Nonspecific Lipid Transfer Protein Superfamily. Biochemical and Biophysical Research Communications. 285(3). 633–638. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heinz Schmidli Breakdown of academic impact, for papers by Volker Fischer Breakdown of academic impact, for papers by Cynthia Grondin Breakdown of academic impact, for papers by Yin Huang Breakdown of academic impact, for papers by Philip T. Sager Breakdown of academic impact, for papers by Maria Teresa Rocchetti Breakdown of academic impact, for papers by Stefan Krämer Breakdown of academic impact, for papers by Lars Kuepfer Breakdown of academic impact, for papers by Norman Stockbridge Breakdown of academic impact, for papers by Daisuke Nakai
Rankless by CCL
2026